News
New Drug Launched
Orphalan announces US commercial launch of Cuvrior™ for the treatment of Wilson disease.
Mailing address:
Wilson Disease Association
224 W 35th St Ste 500
#676
New York, NY 10001
Phone: 414-961-0533
Toll free: 866-961-0533
Follow us on social media
Wilson Disease Association is a Section 501(c)(3) nonprofit.
EIN 16-1154397
©Copyright 2024 Wilson Disease Association | All Rights Reserved | Site Design and Development by Digital Dialogue, Inc